Anthropic has blocked third-party coding tools and rival xAI while releasing Claude Code 2.1.0 to secure its ecosystem ahead ...
Dubai, United Arab Emirates — Genetec Inc. (“Genetec”), the global leader in enterprise physical security software, will ...
Genentech, a member of the Roche Group, said the U.S. Food and Drug Administration approved its treatment for follicular lymphoma. The therapy, Lunsumio VELO, can be used to treat adult patients with ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved CD20xCD3 bispecific Lunsumio VELO ™ ...
– Approval supported by data demonstrating compelling complete response rate in third-line or later follicular lymphoma, which typically becomes harder to treat after each relapse – SOUTH SAN ...
– Approval supported by data demonstrating compelling complete response rate in third-line or later follicular lymphoma, which typically becomes harder to treat after each relapse – Genentech, a ...
The agreement includes $25 million in upfront and near-term payments and could bring Caris up to $1.1 billion in milestone payments tied to research, development and sales, the companies said. Sign up ...
A flurry of dealmaking hasn’t let up as 2025 comes to a close, with Roche subsidiary Genentech getting in on the action and crafting a multi-year cancer collaboration with Caris Life Sciences.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback